Co-Authors
This is a "connection" page, showing publications co-authored by Esam Azhar and Salwa Hindawi.
Connection Strength
2.435
-
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light. Transfus Clin Biol. 2022 Feb; 29(1):31-36.
Score: 0.962
-
Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light. Transfusion. 2018 01; 58(1):52-59.
Score: 0.746
-
Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia. Healthcare (Basel). 2021 Jan 05; 9(1).
Score: 0.231
-
Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma. Vox Sang. 2021 Jul; 116(6):673-681.
Score: 0.229
-
Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates. Transfus Med. 2019 Dec; 29(6):434-441.
Score: 0.213
-
Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016. J Infect Public Health. 2020 May; 13(5):697-703.
Score: 0.054